Power drug development with AI digital pathology

This week's Fierce Biotech is brought to you by PathAI.
Trouble viewing? Click here.

Mike Montalto, Chief Scientific Officer at PathAI, sat down with Joseph Szustakowski, VP of Translational Bioinformatics at Bristol Myers Squibb, to discuss AI-powered digital pathology. Learn how BMS is unlocking new insights in translational research and development by injecting innovative computational AI-based approaches into the traditional field of pathology.

Attending AACR? Join our CEO Andy Beck for a presentation on new research and advancements in predicting gene expression and signatures from whole-slide images (April 12th 3:00-4:00pm ET). Learn more and register for AACR.

Want to reach 137,000+ Fierce Biotech subscribers with your own message?
Contact [email protected] or call 202-824-5074.

You are currently subscribed as [email protected].
If you no longer wish to receive communications from Fierce Biotech's trusted partners, simply click here to unsubscribe.
Refer to our Privacy Policy.

Questex, LLC
685 3rd Avenue, 21st Floor
New York, NY 10017